Mesoblast Ltd. (MESO)
13.82
-0.46
(-3.26%)
USD |
NASDAQ |
Jun 10, 16:00
13.82
0.00 (0.00%)
After-Hours: 19:51
Mesoblast 1 Year Total Returns (Daily) : 20.51% for June 9, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 09, 2026 | 20.51% |
| June 08, 2026 | 17.05% |
| June 05, 2026 | 20.16% |
| June 04, 2026 | 30.28% |
| June 03, 2026 | 37.63% |
| June 02, 2026 | 39.88% |
| June 01, 2026 | 39.66% |
| May 29, 2026 | 44.19% |
| May 28, 2026 | 34.79% |
| May 27, 2026 | 33.64% |
| May 26, 2026 | 37.33% |
| May 22, 2026 | 40.35% |
| May 21, 2026 | 33.04% |
| May 20, 2026 | 25.82% |
| May 19, 2026 | 25.97% |
| May 18, 2026 | 24.91% |
| May 15, 2026 | 25.44% |
| May 14, 2026 | 30.68% |
| May 13, 2026 | 23.68% |
| May 12, 2026 | 27.22% |
| May 11, 2026 | 32.27% |
| May 08, 2026 | 29.18% |
| May 07, 2026 | 33.94% |
| May 06, 2026 | 45.31% |
| May 05, 2026 | 39.73% |
| Date | Value |
|---|---|
| May 04, 2026 | 32.78% |
| May 01, 2026 | 31.83% |
| April 30, 2026 | 37.46% |
| April 29, 2026 | 30.56% |
| April 28, 2026 | 33.33% |
| April 27, 2026 | 29.70% |
| April 24, 2026 | 30.78% |
| April 23, 2026 | 39.64% |
| April 22, 2026 | 44.94% |
| April 21, 2026 | 57.39% |
| April 20, 2026 | 54.94% |
| April 17, 2026 | 53.54% |
| April 16, 2026 | 56.06% |
| April 15, 2026 | 46.24% |
| April 14, 2026 | 36.03% |
| April 13, 2026 | 44.97% |
| April 10, 2026 | 44.23% |
| April 09, 2026 | 31.32% |
| April 08, 2026 | 38.78% |
| April 07, 2026 | 31.59% |
| April 06, 2026 | 40.68% |
| April 02, 2026 | 25.30% |
| April 01, 2026 | 32.77% |
| March 31, 2026 | 23.24% |
| March 30, 2026 | 18.66% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Propanc Biopharma, Inc. | -99.26% |
| Telix Pharmaceuticals Ltd. | -44.35% |
| Amplia Therapeutics Ltd. | 185.7% |
| Immutep Ltd. | -79.95% |
| Fate Therapeutics, Inc. | 25.00% |